Miniatura

Fitxers

689448.pdf (1.36 MB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2019-01-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/140921

Nuclear localization and phosphorylation modulate pathological effects of α-synuclein

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1093/hmg/ddy326

Resum

Alpha-synuclein (aSyn) is a central player in Parkinson's disease (PD) but the precise molecular mechanisms underlying its pathogenicity remain unclear. It has recently been suggested that nuclear aSyn may modulate gene expression, possibly via interactions with DNA. However, the biological behavior of aSyn in the nucleus and the factors affecting its transcriptional role are not known. Here, we investigated the mechanisms underlying aSyn-mediated transcription deregulation by assessing its effects in the nucleus and the impact of phosphorylation in these dynamics. We found that aSyn induced severe transcriptional deregulation, including the downregulation of important cell cycle-related genes. Importantly, transcriptional deregulation was concomitant with reduced binding of aSyn to DNA. By forcing the nuclear presence of aSyn in the nucleus (aSyn-NLS), we found the accumulation of high molecular weight aSyn species altered gene expression and reduced toxicity when compared to the wild-type or exclusively cytosolic protein. Interestingly, nuclear localization of aSyn, and the effect on gene expression and cytotoxicity, was also modulated by phosphorylation on serine 129. Thus, we hypothesize that the role of aSyn on gene expression and, ultimately, toxicity, may be modulated by the phosphorylation status and nuclear presence of different aSyn species. Our findings shed new light onto the subcellular dynamics of aSyn and unveil an intricate interplay between subcellular location, phosphorylation, and toxicity, opening novel avenues for the design of future strategies for therapeutic intervention in PD and other synucleinopathies.

Matèries

Alfa-sinucleïna, Metabolisme, Fisiologia

Matèries (anglès)

Alpha-synuclein, Metabolism, Physiology

Citació

Col·leccions

Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

PINHO, Raquel, PAIVA, Isabel, JERCIC, Kristina gotovac, FONSECA-ORNELAS, Luis, GERHARDT, Ellen, FAHLBUSCH, Cristiane, GARCIA ESPARCIA, Paula, KERIMOGLU, Cemil, PAVLOU, Maria a., VILLAR PIQUÉ, Anna, SZEGO, Éva, LOPES DA FONSECA, Tomás, ODOARDI, Francesca, SOEROES, Szabolcs, REGO, Ana cristina, FISCHLE, Wolfgang, SCHWAMBORN, Jens c., MEYER, Thomas, KÜGLER, Sebastian, FERRER, Isidro (ferrer abizanda), ATTEMS, Johannes, FISCHER, Andre, BECKER, Stefan, ZWECKSTETTER, Markus, BOROVECKI, Fran, OUTEIRO, Tiago f.. Nuclear localization and phosphorylation modulate pathological effects of α-synuclein. _Human Molecular Genetics_. 2019. Vol. 28, núm. 1, pàgs. 31-50. [consulta: 23 de gener de 2026]. ISSN: 0964-6906. [Disponible a: https://hdl.handle.net/2445/140921]

Exportar metadades

JSON - METS

Compartir registre